(Submitter supplied) The FinHER trial is a multicentre phase 3 randomised adjuvant breast cancer trial that enrolled 1010 patients. The women were randomly assigned to receive three cycles of docetaxel or vinorelbine, followed by three cycles of fluorouracil, epirubicin, and cyclophosphamide.
- Organism:
- Homo sapiens
- Type:
- Expression profiling by array
- Platform:
- GPL13667
- 203 Samples
Download data: CEL